Talphera Stock Investor Sentiment

TLPH Stock   0.64  0.02  3.23%   
Under 72 percent of all Talphera's traders are curious in acquiring. The analysis of overall sentiment of trading Talphera stock suggests that a large number of investors are confidant at this time. Talphera's investing sentiment shows overall attitude of investors towards Talphera.
  
over a month ago at seekingalpha.com         
AcelRx Pharmaceuticals Q3 2024 Earnings Preview
seekingalpha News
over a month ago at finance.yahoo.com         
Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wedne...
Yahoo News
over a month ago at thelincolnianonline.com         
Talphera, Inc. Short Interest Update
news
over a month ago at www.macroaxis.com         
Disposition of 1623 shares by Vincent Angotti of Talphera at 1.3 subject to Rule 16b-3
Macroaxis News
over two months ago at finance.yahoo.com         
Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
Yahoo News
over two months ago at www.macroaxis.com         
Insider Trading
Macroaxis News
over three months ago at businesswire.com         
Ray Therapeutics Appoints Christopher Whitmore as Chief Financial Officer
businesswire News
over three months ago at finance.yahoo.com         
Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Yahoo News
over three months ago at news.google.com         
Talphera CEO Vincent J. Angotti buys 7.6k in company stock - Investing.com
Google News at Macroaxis
over three months ago at www.macroaxis.com         
Acquisition by Vincent Angotti of 7260 shares of Talphera at 1.0466 subject to Rule 16b-3
Macroaxis News
over three months ago at news.google.com         
TLPH Stock Earnings Talphera Beats EPS for Q2 2024 - MSN
Google News at Macroaxis
over three months ago at finance.yahoo.com         
Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anti...
Yahoo News
over three months ago at finance.yahoo.com         
Talphera First Half 2024 Earnings US0.31 loss per share
Yahoo News
over three months ago at gurufocus.com         
Talphera Inc Q2 2024 Earnings Call Transcript Highlights Strategic Advancements and ...
Gurufocus Stories at Macroaxis
over three months ago at insidermonkey.com         
Talphera, Inc. Q2 2024 Earnings Call Transcript
insidermonkey News
Far too much social signal, news, headlines, and media speculation about Talphera that are available to investors today. That information is available publicly through Talphera media outlets and privately through word of mouth or via Talphera internal channels. However, regardless of the origin, that massive amount of Talphera data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Talphera news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Talphera relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Talphera's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Talphera alpha.

Talphera Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Insider Trading
10/01/2024
2
Disposition of 1623 shares by Vincent Angotti of Talphera at 1.3 subject to Rule 16b-3
10/25/2024
3
Talphera Upgraded by Maxim Group to Strong-Buy Rating
11/12/2024
4
AcelRx Pharmaceuticals GAAP EPS of -0.13 beats by 0.07
11/13/2024
5
Talphera, Inc. Q3 2024 Earnings Call Transcript
11/15/2024
6
Acquisition by Vincent Angotti of 5000 shares of Talphera at 0.7299 subject to Rule 16b-3
11/27/2024
7
Talphera CEO Vincent J. Angotti buys 3,649 in company stock
12/02/2024
8
Acquisition by Vincent Angotti of 5000 shares of Talphera at 0.6399 subject to Rule 16b-3
12/05/2024

Complementary Tools for Talphera Stock analysis

When running Talphera's price analysis, check to measure Talphera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Talphera is operating at the current time. Most of Talphera's value examination focuses on studying past and present price action to predict the probability of Talphera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Talphera's price. Additionally, you may evaluate how the addition of Talphera to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Transaction History
View history of all your transactions and understand their impact on performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum